98%
921
2 minutes
20
Desmoid fibromatosis (DF) is a refractory tumor with a high recurrence rate, resulting in severe organ's deformity, morbidity, and mortality. The cellular characteristics of DF remain elusive. Herein, we performed single-cell RNA sequencing (scRNA-seq) to reveal the cell landscape of DF. To uncover the exclusive characteristics of DF, we compared the transcriptional profile of DF with that of keloid fibroblast (KF) and normal fibroblast (NF) in the public data (GSE163973). When compared with KF and NF, mesenchymal fibroblasts were significantly expanded in DF. The mesenchymal fibroblasts were further divided into two subtypes according to the differentiation states, among which LAMP5 SULF1 fibroblasts may account for the hard property of DF by promoting tumor ossification. ADAM12 and CREB3L1 were identified as the specific marker and transcription factor for DF, respectively. Both the quiescent and proliferative COL11A1 neural cells exerted dominant roles in the maintenance of the profibrotic microenvironment in DF through modulating extracellular matrix. This study revealed the heterogeneity of fibroblasts in DF for the first time. The novel gene markers and transcription factor identified in DF and the significance of neural cells in the tumor microenvironment may point to new directions for the targeted therapy of DF in the future.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/cas.70160 | DOI Listing |
J Surg Case Rep
August 2025
Department of Thoracic Surgery, Mater Misericordiae University Hospital Dublin, Eccles St, D07 R2WY, Ireland.
Desmoid tumors of the chest wall are rare and pose specific challenges in diagnosis, resection and reconstruction. While not known to have potential for metastasis, they have a high risk of recurrence following resection, even with negative margins. Adequate resection has the potential to leave large thoracic defects, the reconstruction of which are technically challenging and often require a multi-disciplinary surgical skill set.
View Article and Find Full Text PDFFuture Oncol
September 2025
Sarcoma and Early Drug Development, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
The gamma secretase (GS) enzyme controls cell-cell adhesion, neural stem cell proliferation, neo-angiogenesis, spinal maturation, and metabolism of amyloid precursor proteins (APP). Pathological production of abnormal amyloid-beta isoforms and senile plaques serves as the basis for pathogenesis of Alzheimer's disease (AD). GS enzyme inhibitors such as semagacestat and avagacestat were explored in AD but the studies were paused because of adverse events attributed to their influence on the Notch pathway.
View Article and Find Full Text PDFJ Breast Cancer
August 2025
Department of Surgery, Jeonbuk National University Medical School, Jeonju, Korea.
Ribociclib combined with an aromatase inhibitor (AI) is widely used as first-line therapy for hormone receptor (HR)-positive, human epidermal growth factor receptor-2 (HER-2)-negative metastatic breast cancer. Desmoid-type fibromatosis (DTF) is a rare, locally invasive soft-tissue tumor that accounts for only 0.2% of all breast neoplasms and can mimic malignancy upon imaging.
View Article and Find Full Text PDFJ Surg Case Rep
August 2025
Colorectal Surgery Unit, General Surgery Department, Hamad Medical Corporation, Doha, Qatar.
Desmoid tumors are rare, benign, slow-growing, fibroblastic neoplasms that originate from musculoaponeurotic structures throughout the body. Desmoid tumors originating from the abdominal wall or retroperitoneum are extraintestinal lesions that can rarely infiltrate the small bowel or stomach, let alone compress the colon, which is an extraordinary incident leading to mechanical bowel obstruction. Here, we present a rare case of large bowel obstruction caused by a desmoid tumor originating mostly from the abdominal wall that invaded the splenic flexure and stomach in a patient with no history of familial adenomatous polyposis or prior surgical procedures.
View Article and Find Full Text PDFCancer Med
August 2025
Division of Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Background: Desmoid tumors are benign tumors without metastatic potential. While progression is rarely life-threatening, it is often life-affecting with significant morbidity. The rarity of desmoid tumors and the inability to accurately predict their natural history lead to challenges in developing treatment algorithms or formulaic discussions to address treatment options with patients.
View Article and Find Full Text PDF